Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression

Marina Fanin, Anna Chiara Nascimbeni, Luigi Fulizio, Carlo Pietro Trevisan, Marija Meznaric-Petrusa, Corrado Angelini

Research output: Contribution to journalArticle

Abstract

The diagnosis of limb girdle muscular dystrophy (LGMD) type 2A (due to mutations in the gene encoding for calpain-3) is currently based on protein analysis, but mutant patients with normal protein expression have also been identified. In this study we investigated 150 LGMD patients with normal calpain-3 protein expression, identified gene mutations by an allele-specific polymerase chain reaction test, and analyzed the mutant calpain-3 catalytic activity. Four different mutations were found in eight patients (5.5%): a frame-shifting deletion (550 A del) and three missense (R490Q, R489Q, R490W). Patients with normal calpain-3 protein expression on Western blot are a considerable proportion (20%) of our total LGMD2A population. While in control muscle the calpain-3 Ca++-dependent autocatalytic activity was evident within 5 minutes and was prevented by ethylene diaminetetraacetic acid, in all mutant patient samples the protein was not degraded, indicating that the normal autocatalytic function had been lost. By this new functional test, we show that conventional protein diagnosis fails to detect some mutant proteins, and prove the pathogenetic role of R490Q, R489Q, R490W missense mutations. We suggest that these mutations impair protein activity by affecting interdomain protein interaction, or reduce autocatalytic activity by lowering the Ca ++ sensitivity.

Original languageEnglish
Pages (from-to)1929-1936
Number of pages8
JournalAmerican Journal of Pathology
Volume163
Issue number5
Publication statusPublished - Nov 2003

Fingerprint

Calpain
Proteins
Mutation
Mutant Proteins
Limb-Girdle Muscular Dystrophies
Missense Mutation
Limb-girdle muscular dystrophy type 2A
Western Blotting
Alleles
Gene Expression
Muscles
Polymerase Chain Reaction
Acids
Population
Genes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Fanin, M., Nascimbeni, A. C., Fulizio, L., Trevisan, C. P., Meznaric-Petrusa, M., & Angelini, C. (2003). Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression. American Journal of Pathology, 163(5), 1929-1936.

Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression. / Fanin, Marina; Nascimbeni, Anna Chiara; Fulizio, Luigi; Trevisan, Carlo Pietro; Meznaric-Petrusa, Marija; Angelini, Corrado.

In: American Journal of Pathology, Vol. 163, No. 5, 11.2003, p. 1929-1936.

Research output: Contribution to journalArticle

Fanin, M, Nascimbeni, AC, Fulizio, L, Trevisan, CP, Meznaric-Petrusa, M & Angelini, C 2003, 'Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression', American Journal of Pathology, vol. 163, no. 5, pp. 1929-1936.
Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M, Angelini C. Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression. American Journal of Pathology. 2003 Nov;163(5):1929-1936.
Fanin, Marina ; Nascimbeni, Anna Chiara ; Fulizio, Luigi ; Trevisan, Carlo Pietro ; Meznaric-Petrusa, Marija ; Angelini, Corrado. / Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression. In: American Journal of Pathology. 2003 ; Vol. 163, No. 5. pp. 1929-1936.
@article{1bd97a1e405f43019104908231457bb9,
title = "Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression",
abstract = "The diagnosis of limb girdle muscular dystrophy (LGMD) type 2A (due to mutations in the gene encoding for calpain-3) is currently based on protein analysis, but mutant patients with normal protein expression have also been identified. In this study we investigated 150 LGMD patients with normal calpain-3 protein expression, identified gene mutations by an allele-specific polymerase chain reaction test, and analyzed the mutant calpain-3 catalytic activity. Four different mutations were found in eight patients (5.5{\%}): a frame-shifting deletion (550 A del) and three missense (R490Q, R489Q, R490W). Patients with normal calpain-3 protein expression on Western blot are a considerable proportion (20{\%}) of our total LGMD2A population. While in control muscle the calpain-3 Ca++-dependent autocatalytic activity was evident within 5 minutes and was prevented by ethylene diaminetetraacetic acid, in all mutant patient samples the protein was not degraded, indicating that the normal autocatalytic function had been lost. By this new functional test, we show that conventional protein diagnosis fails to detect some mutant proteins, and prove the pathogenetic role of R490Q, R489Q, R490W missense mutations. We suggest that these mutations impair protein activity by affecting interdomain protein interaction, or reduce autocatalytic activity by lowering the Ca ++ sensitivity.",
author = "Marina Fanin and Nascimbeni, {Anna Chiara} and Luigi Fulizio and Trevisan, {Carlo Pietro} and Marija Meznaric-Petrusa and Corrado Angelini",
year = "2003",
month = "11",
language = "English",
volume = "163",
pages = "1929--1936",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression

AU - Fanin, Marina

AU - Nascimbeni, Anna Chiara

AU - Fulizio, Luigi

AU - Trevisan, Carlo Pietro

AU - Meznaric-Petrusa, Marija

AU - Angelini, Corrado

PY - 2003/11

Y1 - 2003/11

N2 - The diagnosis of limb girdle muscular dystrophy (LGMD) type 2A (due to mutations in the gene encoding for calpain-3) is currently based on protein analysis, but mutant patients with normal protein expression have also been identified. In this study we investigated 150 LGMD patients with normal calpain-3 protein expression, identified gene mutations by an allele-specific polymerase chain reaction test, and analyzed the mutant calpain-3 catalytic activity. Four different mutations were found in eight patients (5.5%): a frame-shifting deletion (550 A del) and three missense (R490Q, R489Q, R490W). Patients with normal calpain-3 protein expression on Western blot are a considerable proportion (20%) of our total LGMD2A population. While in control muscle the calpain-3 Ca++-dependent autocatalytic activity was evident within 5 minutes and was prevented by ethylene diaminetetraacetic acid, in all mutant patient samples the protein was not degraded, indicating that the normal autocatalytic function had been lost. By this new functional test, we show that conventional protein diagnosis fails to detect some mutant proteins, and prove the pathogenetic role of R490Q, R489Q, R490W missense mutations. We suggest that these mutations impair protein activity by affecting interdomain protein interaction, or reduce autocatalytic activity by lowering the Ca ++ sensitivity.

AB - The diagnosis of limb girdle muscular dystrophy (LGMD) type 2A (due to mutations in the gene encoding for calpain-3) is currently based on protein analysis, but mutant patients with normal protein expression have also been identified. In this study we investigated 150 LGMD patients with normal calpain-3 protein expression, identified gene mutations by an allele-specific polymerase chain reaction test, and analyzed the mutant calpain-3 catalytic activity. Four different mutations were found in eight patients (5.5%): a frame-shifting deletion (550 A del) and three missense (R490Q, R489Q, R490W). Patients with normal calpain-3 protein expression on Western blot are a considerable proportion (20%) of our total LGMD2A population. While in control muscle the calpain-3 Ca++-dependent autocatalytic activity was evident within 5 minutes and was prevented by ethylene diaminetetraacetic acid, in all mutant patient samples the protein was not degraded, indicating that the normal autocatalytic function had been lost. By this new functional test, we show that conventional protein diagnosis fails to detect some mutant proteins, and prove the pathogenetic role of R490Q, R489Q, R490W missense mutations. We suggest that these mutations impair protein activity by affecting interdomain protein interaction, or reduce autocatalytic activity by lowering the Ca ++ sensitivity.

UR - http://www.scopus.com/inward/record.url?scp=0142151077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142151077&partnerID=8YFLogxK

M3 - Article

C2 - 14578192

AN - SCOPUS:0142151077

VL - 163

SP - 1929

EP - 1936

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -